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Streptomyces chrysomallus synthesizes a mixture of chromopeptide antibiotics, the actinomycins, which differ solely at the 'D-valine-Dalloisoleucine' positions of the peptides ( Fig. 1 ) (Brockmann, 1960) . Actinomycin IV represents approximately 8 to 10% of the mixture formed in chemically defined media containing glycine or nitrate as the sole nitrogen source; however, it may increase to as much as 83 % of the actinomycins produced if DL-valine is added to the medium (Schmidt-Kastner, 1956a) . Whether D-, L-, or both isomers of valine are important for the augmented synthesis of actinomycin IV is not evident from the data presented. It has further ' Present address: Laboratory of Clinical Biochemistry, National Heart Institute, National Institutes of Health, Bethesda, Md.
2 Present address: The Institute for Cancer Research, Lankenau Hospital, Philadelphia, Pa. been shown that supplementation of a nitrateglycerol medium with DL-isoleucine results in the formation of two new actinomycins (Schmidt- Kastner, 1956a, b) . These antibiotics, designated actinomycins El and E2, contain 1 and 2 moles of N-methylisoleucine, respectively, instead of a corresponding number of N-methylvaline residues.
In contrast, the actinomycins produced by Streptomyces antibioticus each contain 2 moles of D-valine per mole of antibiotic (Roussos and Vining, 1956; Johnson and Mauger, 1959) . It was demonstrated that D-valine, D-isoleucine, Dalloisoleucine, and a-methyl-DL-valine inhibit actinomycin synthesis by the organism (Katz, 1960) . -Valine, on the other hand, reversed the inhibition due to D-valine and a-methyl-DLvaline, and stimulated actinomycin synthesis when employed in the absence of the D-isomer. It was suggested that L-rather than D-valine is probably the precursor of the D-valine present in an actinomycin molecule. Recently, Kawamata, Kimura, and Fujita (1960) confirmed the fact that D-isoleucine is an inhibitor of actinomycin formation; moreover, they reported that L-iSOleucine and D-and L-threonine reversed the inhibition.
In light of these results it was of interest to investigate the influence of the various isomeric forms of valine and isoleucine upon actinomycin formation by S. chrysomallus. The findings of these studies are presented in this communication.
MATERIALS AND METHODS
S. chrysomallus strain 3657 was used throughout the investigation. The method of cultivation, composition of the glutamic acid-galactosemineral salts medium (basal medium) for production of actinomycin, procedure for collecting the mycelium formed during growth, and microbiological assay technique for determining the antibiotic titer of culture filtrates have been 600 described previously (Goss and Katz, 1957; Katz, Pienta, and Sivak, 1958; Katz and Goss, 1959) . Actinomycins IV, VI, and VII possess similar antimicrobial activity; therefore, a crystalline preparation of actinomycin IV was employed as assay standard. The D-, I-, and DL-valine, the D-and Lthreonine, and the D-alloisoleucine were obtained from the California Corporation for Biochemical Research. The D-, L-, and DL-isoleucine were purchased from the Nutritional Biochemicals Corporation. The D-alloisoleucine was described as purity grade B.
Unless stated, the amino acids were added to the medium at the time antibiotic production began, i.e., 12 to 24 hr after inoculation of the organism. Duplicate flasks were used for each test series.
The actinomycin mixture synthesized by S. chrysomallus was extracted from culture fluids with n-butanol and concentrated to dryness in a Rinco rotary flash evaporator. The actinomycin mixtures were separated by circular paper chromatography with the solvent system: 10% aqueous sodium-o-cresotinate, n-dibutyl ether, and symmetrical tetrachloroethane (4:3:1) (Katz et al., 1958; Katz and Goss, 1959) . Determination of the percentage of a component in an actinomycin mixture was carried out by a spectrophotometric method (Goss and Katz, 1957) .
RESULTS
Influence of D-, L-, and DL-valine on actinomycin formation and growth of S. chrysomallus. 1) DValine:-As observed previously with S. antibioticus (Katz, 1960) , D-valine markedly inhibits actinomycin synthesis by S. chrysomallus; the extent to which antibiotic formation is blocked depends upon the concentration of D-valine used and the length of incubation of the organism (Fig.  2) . It can further be seen that the inhibition was particularly striking early in the fermentation.
D-Valine probably interferes directly with some stage in the synthesis of the actinomycin molecule rather than with the growth of the organism, since the amount of mycelium produced in the presence of inhibitory concentrations of the Disomer is about equal to or greater than that synthesized with no valine added (Table 1) .
Although total synthesis of actinomycin is greatly depressed under these conditions, there is generally a limited but transitory increase in the amount of actinomycin IV in the mixture formed. This increase usually occurs after a few days of incubation in the presence of the D-isomer. In one experiment in which 500 Mig of D-valine per ml were added to flasks, it was noted, after an additional 4 days of incubation, that actinomycin production was checked appreciably (89%) and that actinomycin IV represented 38% of the mixture elaborated. Following 2 more days of cultivation, antibiotic synthesis still was inhibited markedly (53%), whereas actinomycin IV represented only 18% of the actinomycin mixture.
2) L-Valine:-Production of all actinomycins increases after L-valine is added to the medium ( (Fig. 3) . At a concentration of 500 ,ug per ml, the D-isomer, supplied to cultures of S. chrysomallus after 3, 4, 5, or 6 days of incubation, essentially checked further synthesis of actinomycin. When D-valine was supplied prior to antibiotic formation, synthesis was blocked for about 5 days. Subsequently, rapid production occurred and, by 7 days, the titer of culture filtrates was approximately 45%T of that attained in control flasks.
L-Valine was found to increase over-all antibiotic production and to selectively stimulate synthesis of actinomycin IV, whether it was supplied before or during antibiotic formation. The maximal percentage of actinomycin IV, attained in a given mixture after L-valine (1,000 A.g per ml) supplementation, ranged from a high of 89.1% (addition at time of inoculation) to a low of 45.4% (addition at 5 days).
Influence of D-valine on actinomycin synthesis in the presence of L-valine. Actinomycin IV invariably constitutes a greater percentage of the mixture synthesized when DL-valine is employed rather than the L-or D-isomer (at one-half the DL-concentration) ( D-valine (Table 3 ). The reversal does not appear to be the result of increased growth followed by greater antibiotic production. Mycelium formation in the various experimental series did not exceed that produced in control flasks by more than 10 to 15 %; moreover, enhanced growth of the organism occurred in flasks containing D-, L-, or mixtures of both isomers.
Influence of isoleucine and threonine isomers on actinomycin formation. 1) Isoleucine.:-In certain experiments we observed that L-isoleucine, at concentrations of 500 ug per ml or more, selectively stimulated actinomycin VII synthesis, whereas formation of actinomycins IV and VI was markedly curtailed (Table 4 , Fig. 4 Two new actinomycins (which appear to be the same substances as those formed in the presence of L-isoleucine) are synthesized when the organism is grown with D-isoleucine (Table 4) . These components constitute significant amounts of the actinomycin mixture elaborated even at comparatively low levels of the D-isomer (10 ,ug per ml); optimal synthesis of these actinomycins (30 to 35% of each component) occurred when 50 to 100 ,ug D-isoleucine per ml were employed (Fig.  4) .
The results obtained with DL-isoleucine ( (Table 4) . The inhibition of synthesis with isoleucine was observed. The antibiotic potency of certain filtrates from cultures grown in media containing any of the isoleucine isomers was reduced by as much as 50 to 90% (Table 4 ). Since growth of the organism was not inhibited under these conditions, the apparent inhibition of antibiotic production may be due to decreased potency of the new actinomycins synthesized or to an actual depression of actinomycin formation or both. As the microbiological activity of the new actinomycins has not been reported to date, it is not possible to decide which factor is responsible for the reduced antibiotic titers.
2) Threonine:-The relationship of threonine to isoleucine biosynthesis in Neurospora crassa and Escherichia coli is well established (Abelson, 1954; Adelberg, 1954 Adelberg, , 1955a Synthesis of actinomycins by Streptomyces chrysomallus in the presence of various isomers of isoleucine. S. chrysomallus was grown in the basal medium to which a given isomer of isoleucine was added 12 hr after inoculation. The actinomycin mixture synthesized was isolated 3 days later and was separated by circular paper chromatography as described in Materials and Methods. Sequence of actinomycins is from center to periphery; in all cases, the first zone just beyond the origin constitutes biologically inactive, colored material. A, basal medium: actinomycins IV, VI, and VII. B, basal medium plus L-isoleucine, 1,000 ,Ag per ml: actinomycin IV (trace), VI, VII, E1 and E2. C, basal medium plus D-alloisoleucine, 500 ,ug per ml: actinomycin IV (trace, not evident) VI, VII, E1 and E2. D, basal medium plus D-isoleucine, 500,g per ml: actinomycin IV (trace, not evident), VI, VII, E1, and E2. E, basal medium plus DL-isoleucine, 600 ;pg per ml: actinomycin IV (trace, not evident), VI, VII, El, and E2.
than that occurring in control flasks and there is synthesis of actinomycins El (D-and L-threonine) and E2 (D-threonine).
Influence of simultaneous addition of L-valine and L-isoleucine or D-isoleucine. The simultaneous addition of both L-valine and L-isoleucine to the medium reduces, to some extent, the effectiveness of either compound upon actinomycin biosynthesis (Table 5) . Thus, with both amino acids present, actinomycin El synthesis declines appreciably and there is much less production of actinomycin IV in comparison with cultures Influence of L-isoleucine and D-isoleucine additions. The addition of increasing concentrations of L-isoleucine (100 to 1,000 ,ug per ml) to a given amount of D-isoleucine (50 to 250 ,ug per ml) results in greater synthesis of actinomycin VII (from 23 to 43%) and a decline in actinomycin E2 production (32 to 11%); actinomycin E1 formation remains virtually unchanged (32 to 37%).
DISCUSSION
The observation that D-valine is an effective inhibitor of actinomycin synthesis by S. chrysomallus, whereas L-valine stimulates its formation and reverses the inhibition due to the D-enantiomorph, is similar to that reported previously for S. antibioticus (Katz, 1960) . L-Valine, in particular, enhances actinomycin IV synthesis. These data provide further evidence for the hypothesis that L-valine is used in preference to added D-valine for synthesis of the D-valine present in actinomycin. It is suggested that, during the biosynthesis of an actinomycin molecule, the L-amino acid or its keto analogue is incorporated into a growing peptide and that the D-configuration of the amino acid arises in a succeeding reaction. D-Valine may inhibit this process.
The penicillamine moiety of penicillin (derived from valine) has the D-configuration, and D-valine residues are present in valinomycin. In both instances, isotopic studies with C'4-labeled D-and L-valine have shown that L-valine is preferentially utilized for synthesis of the Dvaline moiety of the antibiotic (Arnstein and Margreiter, 1958; MacDonald, 1960) . Radioisotope studies should also provide more definitive answers to the relationship of D-and L-valine to actinomycin biosynthesis.
The fact that L-isoleucine stimulates actinomycin VII synthesis suggests that L-isoleucine, rather than D-alloisoleucine, is used for synthesis of the D-alloisoleucine in actinomycin. It is conceivable that the same type of mechanism employed by the cell for D-valine synthesis is used for D-alloisoleucine formation. Further discussion of this point will be considered below. In experiments in which we failed to obtain a significant increase in actinomycin VII production, enhanced synthesis of actinomycin E1, and the elaboration of a second new actinomycin, E2, occurred. The reason(s) for the shift from synthesis of actinomycin VII to greater production of actinomycin El and E2 is not immediately evident.
We propose a tentative hypothesis (illustrated in Fig. 5 ) to explain the results which have been obtained with the various isoleucine and threonine isomers.
L-Isoleucine and D-alloisoleucine yield the same keto analogue, L-a-keto-/3-methylvaleric acid (Meister, 1951 (Meister, , 1952 . Cell-free extracts of S. chrysomallus catalyze transamination between L-isoleucine and a-ketoglutaric acid to yield Lglutamic acid (unpublished results) and, presumably, L-a-keto-f3-methylvaleric acid. The latter compound, once formed, might then undergo transamination or reductive amination to yield D-alloisoleucine (Meister, 1952) . Brown, 1956), giving rise to a-ketobutyric acid, which lies directly on the pathway of L-isoleucine biosynthesis (Willson and Adelberg, 1957) . The conversion of D-and L-threonine to L-isoleucine via a-ketobutyric acid may occur by the same mechanism in S. chrysomallus and thus explain why both isomers of threonine exhibit an effect similar to that observed with L-isoleucine.
The configuration of the p3-carbon atom of methylisoleucine found in actinomycin El and E2 has not yet been reported (Schmidt-Kastner, 1956 a,b; Brockmann, 1960) . The order of effectiveness of the various amino acids tested as "precursors" for actinomycin El and E2 synthesis is D-isoleucine > D-alloisoleucine > L-isoleucine > D-threonine > L-threonine. If one can relate the effectiveness of a compound to its proximity to the final reaction product, this order of activity suggests that the N-methylamino acid is the Lalloisoleucine form. Oxidation of D-isoleucine would yield D-a-keto-f3-methylvaleric acid (Meister, 1951 ) which, in turn, might undergo transamination to form L-alloisoleucine. Methylation of the latter compound would give rise to Nmethyl-L-alloisoleucine (Fig. 5) . One additional reaction, the racemization of L-a-keto-f-methylvaleric acid to the D-a-keto acid (Meister, 1952) , would be required to convert D-alloisoleucine to N-methyl-L-alloisoleucine. The rapid metabolism of L-isoleucine, plus its conversion to D-alloisoleucine, would reduce the effectiveness of this amino acid for actinomycin E1 and E2 formation as our data reveal. Finally, L-and Dthreonine, by virtue of loss through metabolism as threonine and subsequently, after conversion, as isoleucine, probably would make the least suitable precursor compounds. Conceivably, Nmethyl-L-isoleucine, rather than N-methyl-Lalloisoleucine, is the amino acid incorporated into actinomycins El and E2. However, this possibility seems to us to be the less likely one.
